Contents

Search


endometrial dysplasia/hyperplasia

Etiology: - unopposed estrogen in women taking hormone replacement therapy increase risk - tamoxifen increases endometrial hyperplasia Clinical manifestations: - abnormal uterine bleeding (most common presenting symptom) Laboratory: - endometrial biopsy for atypia Special laboratory: - pelvic ultrasound for endometrial thickness Complications: - endometrial carcinoma - dysfunctional uterine bleeding Management: - endometrial hyperplasia without atypia responds well to progestins - hysterectomy for women with atypia, unless contraindicated [2]

Related

endometrium

General

epithelial dysplasia uterine disease

References

  1. Yi X, Zheng W. Endometrial glandular dysplasia and endometrial intraepithelial neoplasia. Curr Opin Obstet Gynecol. 2008 Feb;20(1):20-5. PMID: 18197001
  2. Montgomery BE et al Endometrial hyperplasia: a review. Obstet Gynecol Surv. 2004 May;59(5):368-78. PMID: 15097798